Company Overview of Labesfal - Laboratórios Almiro S.A.
Labesfal - Laboratórios Almiro S.A. manufactures and markets generic and intravenously administered drugs for therapeutic areas. The company’s products are used in the treatment of anti-infective, cardiovascular, analgesic, antipyretic, gastroenterologic, anti-histamine, and central nerves system related diseases. The company was founded in 1981 and is based in Tondela, Portugal. As of March 16, 2005, Labesfal - Laboratórios Almiro S.A. operates as a subsidiary of Fresenius Kabi AG.
Zona Industrial do Lagedo
Santiago de Besteiros
Founded in 1981
351 23 283 1100
351 23 283 1112
Key Executives for Labesfal - Laboratórios Almiro S.A.
Labesfal - Laboratórios Almiro S.A. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Atral Cipan SGPS, S.A.||Europe|
|Bial - S.G.P.S., S.A.||Europe|
|Blue Pharma-Indústria Farmacêutica, SA||Europe|
|Davi II-Farmaceutica, S.A.||Europe|
|Decomed, Sociedade Farmacêutica, S.A.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Labesfal - Laboratórios Almiro S.A., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.